bill putting prescription label info on a free app

The text as introduced · 496 words

89R13930 AND-D

By: Menéndez
S.B. No. 2470

A BILL TO BE ENTITLED

AN ACT

relating to the requirements for the labeling and dispensing of a

prescription drug or biological product.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Section 562.006, Occupations Code, is amended by

amending Subsections (b) and (f) and adding Subsection (g) to read

as follows:

(b) In addition to the information required by Subsection

(a), the label on the dispensing container of a drug or biological

product dispensed by a Class A or Class E pharmacy must [ indicate ]:

(1) indicate:

(A) the name, address, and telephone number of

the pharmacy;

(B) [ (2) ] the date the prescription is

dispensed;

(C) [ (3) ] the name of the prescribing

practitioner;

(D) [ (4) ] the name of the patient or, if the drug

or biological product was prescribed for an animal, the species of

the animal and the name of the owner;

(E) [ (5) ] instructions for use;

(F) [ (6) ] the quantity dispensed;

(G) [ (7) ] if the drug or biological product is

dispensed in a container other than the manufacturer's original

container, the date after which the prescription should not be

used, determined according to criteria established by board rule

based on standards in the United States Pharmacopeia-National

Formulary; and

(H) [ (8) ] any other information required by

board rule ; and

(2) include, in a format accessible to the patient

through a mobile Internet application or assistive technology

electronic device available to the patient at no cost, the

information described by Subdivision (1) and information regarding

potential side effects and contraindicated medications .

(f) The [ board shall adopt rules requiring the ] label on a

dispensing container must [ to ] be in plain language and printed in

Times New Roman with a minimum of 12-point [ an easily readable ] font

size [ for the consumer ].

(g) A pharmacist at a Class A or Class E pharmacy shall, on a

patient's request, provide to the patient a large-print data sheet

containing:

(1) the information required under Subsection (b)(1)

to be on the label on a dispensing container of a drug or biological

product dispensed to the patient; and

(2) information regarding potential side effects and

contraindicated medications for the drug or biological product

dispensed to the patient.

SECTION 2. Not later than January 1, 2026, the Texas State

Board of Pharmacy shall adopt any rules necessary to implement the

changes in law made by this Act.

SECTION 3. The changes in law made by this Act apply only to

a drug or biological product dispensed on or after March 1, 2026. A

drug or biological product dispensed before March 1, 2026, is

governed by the law in effect immediately before the effective date

of this Act, and the former law is continued in effect for that

purpose.

SECTION 4. This Act takes effect September 1, 2025.